Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Yukai Wang¹, Guangzhou Du², Guohong Zhang³, Marco Matucci-Cerinic⁴, Daniel E Furst⁵

Affiliations

¹ Department of Rheumatology, Shantou Central Hospital, Shantou, Guangdong, China stzxyywyk@126.com.
² Department of Radiology, Shantou Central Hospital, Shantou, Guangdong, China.
³ Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China.
⁴ Department of Experimental and Clinical Medicine, University of Florence, Firenze, Toscana, Italy.
⁵ Department of Rheumatology, University of California Los Angeles, Los Angeles, California, USA.

PMID: 32759260
DOI: 10.1136/annrheumdis-2020-218594

Comment

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Yukai Wang et al. Ann Rheum Dis. 2022 Oct.

. 2022 Oct;81(10):e192.

doi: 10.1136/annrheumdis-2020-218594. Epub 2020 Aug 5.

Authors

Yukai Wang¹, Guangzhou Du², Guohong Zhang³, Marco Matucci-Cerinic⁴, Daniel E Furst⁵

Affiliations

¹ Department of Rheumatology, Shantou Central Hospital, Shantou, Guangdong, China stzxyywyk@126.com.
² Department of Radiology, Shantou Central Hospital, Shantou, Guangdong, China.
³ Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China.
⁴ Department of Experimental and Clinical Medicine, University of Florence, Firenze, Toscana, Italy.
⁵ Department of Rheumatology, University of California Los Angeles, Los Angeles, California, USA.

PMID: 32759260
DOI: 10.1136/annrheumdis-2020-218594

No abstract available

Keywords: autoimmunity; inflammation; pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al.
Lamb JA, Megremis S, Chinoy H. Lamb JA, et al. Ann Rheum Dis. 2022 Oct;81(10):e193. doi: 10.1136/annrheumdis-2020-218712. Epub 2020 Aug 5. Ann Rheum Dis. 2022. PMID: 32759262 No abstract available.

Comment on

Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.
Megremis S, Walker TDJ, He X, Ollier WER, Chinoy H, Hampson L, Hampson I, Lamb JA. Megremis S, et al. Ann Rheum Dis. 2020 Oct;79(10):1383-1386. doi: 10.1136/annrheumdis-2020-217522. Epub 2020 May 22. Ann Rheum Dis. 2020. PMID: 32444414 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Affiliations

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical